140 related articles for article (PubMed ID: 19725224)
1. Bcl-2 in combination to myeloid antigen expression in adult acute lymphoblastic leukemia and prognostic outcome.
Amirghofran Z; Daneshbod Y; Gholijani N
Oncol Res; 2009; 17(10):447-54. PubMed ID: 19725224
[TBL] [Abstract][Full Text] [Related]
2. The influence of Bcl-2 and myeloid antigen expression on response to therapy in childhood acute lymphoblastic leukemia.
Amirghofran Z; Daneshbod Y; Gholijani N; Esmaeilbeig M
Arch Iran Med; 2011 May; 14(3):170-4. PubMed ID: 21529104
[TBL] [Abstract][Full Text] [Related]
3. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
[TBL] [Abstract][Full Text] [Related]
4. Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones.
Firat H; Favier R; Adam M; Leverger G; Landman-Parker J; Cayre Y; Douay L
Leuk Lymphoma; 2001 Jun; 42(1-2):75-82. PubMed ID: 11699224
[TBL] [Abstract][Full Text] [Related]
5. A subset of acute lymphoblastic leukemia with co-expression of myeloid antigens: prevalence and clinical significance.
Hsu PN; Tien HF; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH; Liang DC; Lin KS
J Formos Med Assoc; 1991 Mar; 90(3):225-31. PubMed ID: 1677396
[TBL] [Abstract][Full Text] [Related]
6. Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.
Vitale A; Guarini A; Ariola C; Meloni G; Perbellini O; Pizzuti M; De Gregoris C; Mettivier V; Pastorini A; Pizzolo G; Vignetti M; Mandelli F; Foà R
Haematologica; 2007 Mar; 92(3):342-8. PubMed ID: 17339183
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 expression in acute myelogenous leukemia: the relation to myeloid antigen expression and response to therapy in Iranian patients.
Daneshbod Y; Amirghofran Z; Tabei SZ
Neoplasma; 2005; 52(2):109-14. PubMed ID: 15800708
[TBL] [Abstract][Full Text] [Related]
8. Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones.
Firat H; Favier R; Adam M; Leverger G; Landman-Parker J; Cayre Y; Douay L
Leuk Lymphoma; 2001 Aug; 42(4):675-82. PubMed ID: 11697497
[TBL] [Abstract][Full Text] [Related]
9. Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experience.
Boldt DH; Kopecky KJ; Head D; Gehly G; Radich JP; Appelbaum FR
Leukemia; 1994 Dec; 8(12):2118-26. PubMed ID: 7807999
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications.
Lauria F; Raspadori D; Martinelli G; Rondelli D; Ventura MA; Farabegoli P; Tosi P; Testoni N; Visani G; Zaccaria A
Br J Haematol; 1994 Jun; 87(2):286-92. PubMed ID: 7947269
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of immunophenotypic markers in pediatric T-cell acute lymphoblastic leukemia.
Sidhom I; Shaaban K; Soliman S; Ezzat S; El-Anwar W; Hamdy N; Yassin D; Salem S; Hassanein H; Mansour MT
J Egypt Natl Canc Inst; 2008 Jun; 20(2):111-20. PubMed ID: 20029466
[TBL] [Abstract][Full Text] [Related]
12. Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance.
Den Boer ML; Kapaun P; Pieters R; Kazemier KM; Janka-Schaub GE; Veerman AJ
Br J Haematol; 1999 Jun; 105(4):876-82. PubMed ID: 10554796
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of cross-lineage expression of the myeloid-associated antigens CD13 and CD33 in adult B-lymphoblastic leukemia: A large real-world study of 1005 patients.
Liao H; Lai H; Chen J; Shuai X; Zhang X; Yang Y; Lyu M; Zheng Q
Cancer Med; 2023 Apr; 12(8):9615-9626. PubMed ID: 36951610
[TBL] [Abstract][Full Text] [Related]
14. [The use of monoclonal antibodies for immunologic typing and prognosis prediction in acute non-lymphoblastic leukemia].
Chen GB; Tang MH; Yang TY
Zhonghua Nei Ke Za Zhi; 1993 Jun; 32(6):405-8. PubMed ID: 7903627
[TBL] [Abstract][Full Text] [Related]
15. Enhanced myeloid specificity of CD117 compared with CD13 and CD33.
Nomdedéu JF; Mateu R; Altès A; Llorente A; Rio C; Estivill C; López O; Ubeda J; Rubiol E
Leuk Res; 1999 Apr; 23(4):341-7. PubMed ID: 10229319
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases.
Raponi S; De Propris MS; Intoppa S; Milani ML; Vitale A; Elia L; Perbellini O; Pizzolo G; Foá R; Guarini A
Leuk Lymphoma; 2011 Jun; 52(6):1098-107. PubMed ID: 21348573
[TBL] [Abstract][Full Text] [Related]
17. Clinical importance of myeloid antigen expression in Moroccan patients with adult B-lineage acute lymphoblastic leukemia.
Lahjouji A; Bachir F; Bennani S; Benchekroun S; E SA
Neoplasma; 2013; 60(5):553-60. PubMed ID: 23790175
[TBL] [Abstract][Full Text] [Related]
18. Characterization of immunophenotypic aberrancies in adult and childhood acute lymphoblastic leukemia: A study from Northern India.
Sharma M; Sachdeva MU; Varma N; Varma S; Marwaha RK
J Cancer Res Ther; 2016; 12(2):620-6. PubMed ID: 27461621
[TBL] [Abstract][Full Text] [Related]
19. Acquisition of CD13 and CD33 expression at relapse on acute myeloid leukemia cells with an unusual phenotype: MPO+CD13-CD33-.
Kawada H; Ichikawa Y; Kobayashi N; Fukuda R; Yonekura S; Nagao T
Intern Med; 1993 Sep; 32(9):733-6. PubMed ID: 7908235
[TBL] [Abstract][Full Text] [Related]
20. Stromal-mediated down-regulation of CD13 in bone marrow cells originating from acute myeloid leukemia patients.
Dybkaer K; Olesen G; Pedersen FS; Kristensen JS
Eur J Haematol; 2001 Mar; 66(3):168-77. PubMed ID: 11350485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]